Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11
Closed -$1K 1165
2022
Q3
$1K Hold
11
﹤0.01% 1151
2022
Q2
$1K Sell
11
-88
-89% -$7.27K ﹤0.01% 1145
2022
Q1
$8K Buy
99
+86
+662% +$8.24K ﹤0.01% 821
2021
Q4
$2K Hold
13
﹤0.01% 1080
2021
Q3
$1K Hold
13
﹤0.01% 1118
2021
Q2
$2K Hold
13
﹤0.01% 1079
2021
Q1
$1K Hold
13
﹤0.01% 1148
2020
Q4
$1K Hold
13
﹤0.01% 1011
2020
Q3
$1K Sell
13
-13
-50% -$1.01K ﹤0.01% 993
2020
Q2
$2K Buy
26
+11
+73% +$726 ﹤0.01% 910
2020
Q1
$977 Sell
15
-45
-75% -$3.55K ﹤0.01% 930
2019
Q4
$4.73K Buy
60
+12
+25% +$934 ﹤0.01% 923
2019
Q3
$3.82K Buy
+48
New +$3.77K ﹤0.01% 1067

Other funds holding XYL

Evoke Wealth's XYL Position: Q4 2022 in Review

Evoke Wealth sold out of Xylem (XYL) in Q4 2022, closing a stake of 11 shares — an estimated $1K sold.

Evoke Wealth first reported a position in XYL in Q3 2019 and held it in 13 quarters. The position peaked at $8K in Q1 2022. 818 funds tracked by Wall St. Rank hold XYL as of Q4 2022.

  • Evoke Wealth reported no remaining Xylem position as of Q4 2022 after selling out during the quarter.
  • Evoke Wealth sold 11 Xylem shares in Q4 2022, an estimated $1K.
  • Evoke Wealth first reported a position in Xylem in Q3 2019 and held it in 13 quarters.
  • Evoke Wealth's Xylem position peaked at $8K in Q1 2022.
  • 818 funds tracked by Wall St. Rank held Xylem as of Q4 2022.

Based on Evoke Wealth's 13F filing for Q4 2022, filed 10 Feb 2023.